ライフサイエンスコーパス: valvuloplasty

1 ry (bioprosthesis replacement, valve repair, valvuloplasty).

2 therapy (which often included balloon aortic valvuloplasty).

3 s, TAVI was performed without aortic balloon valvuloplasty.

4 tricular (BV) circulation after fetal aortic valvuloplasty.

5 valve replacement (TAVR), and balloon aortic valvuloplasty.

6 may become the standard approach for mitral valvuloplasty.

7 fants and neonates is trans-catheter balloon valvuloplasty.

8 eatment, which often included balloon aortic valvuloplasty.

9 ented in any of the patients after tricuspid valvuloplasty.

10 ion were assessed before and after tricuspid valvuloplasty.

11 unction both at baseline and after tricuspid valvuloplasty.

12 moderate MR tended to improve without mitral valvuloplasty.

13 atheter aortic valve implantation or balloon valvuloplasty.

14 onse to the transient hypotension induced by valvuloplasty.

15 re and 20 to 30 min after undergoing balloon valvuloplasty.

16 e), an additional 86 aortic and 16 pulmonary valvuloplasties, 37 atrial septal cases, and 6 unclassif

17 Technically successful aortic valvuloplasty alters left heart valvar growth in fetuses

18 lts are obtained with trans-catheter balloon valvuloplasty, although stenosis resistant to further ba

19 and therapeutic purposes, including balloon valvuloplasties and electrophysiologic ablation procedur

20 al among patients who underwent fetal aortic valvuloplasty and achieved a BV circulation postnatally

21 dy sought to compare outcomes after surgical valvuloplasty and balloon dilation of the aortic valve i

22 ty of established procedures such as balloon valvuloplasty and coarctation angioplasty.

23 Percutaneous balloon mitral valvuloplasty and durable mitral prostheses have made th

24 Mitral valvuloplasty and radiofrequency ablation for AF, which

25 long-term studies of trans-catheter balloon valvuloplasty and surgical valvotomy warrant a review of

26 is, having the relief of stenosis by balloon valvuloplasty and undergoing initial treatment as a neon

27 tral valvuloplasty, antegrade balloon aortic valvuloplasty, and ablation of arrhythmias in the LA.

28 All eight patients underwent tricuspid valvuloplasty, and all experienced a decrease in regurgi

29 r in the body time, rapid pacing used during valvuloplasty, and repositioning of the prosthesis.

30 ion of the ductus arteriosus, balloon aortic valvuloplasty, and stenting or angioplasty of Blalock-Ta

31 and 177 (64.6%) treated with balloon aortic valvuloplasty; and group 2 (surgical): 88 (24.3%).

32 formed for procedures such as balloon mitral valvuloplasty, antegrade balloon aortic valvuloplasty, a

33 of patent ductus arteriosus (PDA); pulmonary valvuloplasty; aortic valvuloplasty; coarctation of the

34 ng a surgical AV procedure or aortic balloon valvuloplasty at Children's Hospital of Oklahoma between

35 g mid-term and long-term results for balloon valvuloplasty, balloon atrial septostomy and pulmonary a

36 R) led to renewed interest in balloon aortic valvuloplasty (BAV).

37 unexpected death (SUD) after balloon aortic valvuloplasty (BAVP) for congenital aortic stenosis (AS)

38 Transcatheter balloon aortic valvuloplasty (BAVP) has become the first-line treatment

39 tion in LV pressure load with balloon aortic valvuloplasty (BAVP) may improve diastolic function.

40 Balloon mitral valvuloplasty (BMV) for mitral stenosis is a procedure t

41 immediately before and after balloon mitral valvuloplasty (BMV).

42 nts for congenital MS include balloon mitral valvuloplasty (BMVP), surgical mitral valvuloplasty (SMV

43 Fetal aortic valvuloplasty can be performed for severe midgestation a

44 Fetal aortic valvuloplasty carries a risk of fetal demise.

45 iosus (PDA); pulmonary valvuloplasty; aortic valvuloplasty; coarctation of the aorta angioplasty and

46 Mitral valvuloplasty, consisting of cleft repair (n = 10), and

47 Tricuspid valvuloplasty during either the hemi-Fontan or Fontan st

48 After valvuloplasty, Fick-derived oxygen delivery increased by

49 2008, 70 fetuses underwent attempted aortic valvuloplasty for critical aortic stenosis with evolving

50 uded 100 patients who underwent fetal aortic valvuloplasty for severe midgestation aortic stenosis wi

51 ur at 16 months of age and underwent balloon valvuloplasty for severe valvular aortic stenosis.

52 four patients studied both before and after valvuloplasty, for a total of 21 studies.

53 cases entered, 245 underwent FCI: 100 aortic valvuloplasties from a previous single-center report (ex

54 00 consecutive patients who underwent mitral valvuloplasty from 1987 to 1999.

55 The medical/balloon aortic valvuloplasty group had a higher New York Heart Associat

56 The medical/balloon aortic valvuloplasty group had significantly higher clinical ri

57 ays, mortality in the medical/balloon aortic valvuloplasty group was 102 (37.2%), and during median f

58 had experienced less previous balloon aortic valvuloplasty, had higher left ventricular ejection frac

59 s in patients with critical PS after balloon valvuloplasty has not clearly been defined.

60 Fetal balloon valvuloplasty has shown promise.

61 New advances such as fetal balloon valvuloplasty, improvements in the Ross technique, and l

62 es increased in size after balloon pulmonary valvuloplasty in both groups at a rate that paralleled o

63 After balloon pulmonary valvuloplasty in infants with critical and severe PS, ri

64 en cardiac output was improved after balloon valvuloplasty in patients with aortic stenosis.

65 etermine (1) whether V O2 is increased after valvuloplasty in patients with mitral stenosis, and (2)

66 although transcatheter aortic valvuloplasty is effective for relief of congenital AS,

67 While availability of fetal balloon valvuloplasty is limited, it has promise for promoting i

68 Percutaneous balloon valvuloplasty is the treatment of choice for patients in

69 ere aortic and pulmonary stenoses by balloon valvuloplasty may diminish their postnatal expression.

70 Prenatal balloon aortic valvuloplasty may improve left heart growth and function

71 Fetal aortic valvuloplasty may prevent progression of aortic stenosis

72 Reports of mitral valvuloplasty (MVP) in such patients are few; the altern

73 n fetuses underwent pre-natal cardiac aortic valvuloplasty (n = 8) and/or atrial septal dilation/sten

74 ction (n=9), arch augmentation (n=5), mitral valvuloplasty (n=5), ventricular septal defect closure (

75 d in 51 patients, including aortic valvotomy/valvuloplasty (n=56), coarctation repair (n=21), subaort

76 ation techniques were pioneered with balloon valvuloplasty of pulmonic stenosis in infants.

77 Successful mitral valvuloplasty or replacement was documented by long-term

78 of any type, and particularly with tricuspid valvuloplasty or replacement.

79 o standard therapy (including balloon aortic valvuloplasty) or transfemoral transcatheter implantatio

80 and a greater number of aortic valve balloon valvuloplasties (p = 0.003).

81 By multivariate analysis, balloon valvuloplasty (p < 0.001) and treatment as a neonate (p

82 atients with aortic regurgitation or balloon valvuloplasty patients (no correction).

83 utcome of repeat percutaneous mitral balloon valvuloplasty (PMV) for post-PMV mitral restenosis.

84 phic scoring systems for percutaneous mitral valvuloplasty (PMV) have limitations.

85 Percutaneous mitral balloon valvuloplasty (PMV) results in good immediate results, p

86 ients undergoing percutaneous mitral balloon valvuloplasty (PMV).

87 he NHLBI established the multicenter Balloon Valvuloplasty Registry in November 1987 to assess both s

88 t, Lung, and Blood Institute (NHLBI) Balloon Valvuloplasty Registry.

89 Balloon pulmonary valvuloplasty relieves PS but can cause late PR.

90 Surgical valvuloplasty remains the best approach to treat neonate

91 nction was assessed as fair before tricuspid valvuloplasty repair and improved to good in five of sev

92 intervention vs. traditional balloon aortic valvuloplasty; shunt type in staged palliation for hypop

93 mitral valvuloplasty (BMVP), surgical mitral valvuloplasty (SMVP), and mitral valve replacement (MVR)

94 Hemodynamic data and balloon pulmonary valvuloplasty techniques were reviewed.

95 greater improvements in cardiac output after valvuloplasty than do patients with aortic stenosis, the

96 term results of transcatheter balloon aortic valvuloplasty, the preferred treatment for congenital ao

97 surgery; the benefit of percutaneous balloon valvuloplasty to mortality might be similar to that of s

98 ntervention at 5 years was 27% after balloon valvuloplasty versus 65% after surgery.

99 Balloon pulmonary valvuloplasty was successful in 64% of patients with cri

100 Fetuses undergoing in utero aortic valvuloplasty with an unfavorable multivariable threshol